Gerstner & Sons Expands OEM Production to Meet Rising Demand for U.S.-Based Manufacturing

The Ohio-based woodworking manufacturer scales up domestic production services in response to national reshoring trends and demand for Made in USA solutions.

H. Gerstner & Sons, the nearly 120-year-old woodworking company recognized for its heirloom-quality tool chests, is expanding its OEM production capacity to meet increasing demand for batch-run manufacturing in the United States. The decision comes amid a national shift toward reshoring and greater interest in domestic supply chains, reinforcing the value of the Made in USA manufacturing base.

Recent data from the Reshoring Initiative shows that reshoring and foreign direct investment (FDI) job announcements hit a record 365,000 in 2023—nearly five times higher than levels seen before the pandemic. In response, Gerstner & Sons is opening more of its factory capacity to OEM clients, focusing on brands seeking consistent production runs ranging from 50 to 500 units and emphasizing precision woodworking.

“We’ve built for respected names in tools, lifestyle goods, and retail display,” said Kim Brown, vice president of sales and marketing at Gerstner & Sons. “Our strength is in our consistency, craftsmanship, and commitment to producing in the USA—not in offering the lowest price.”

The company’s expanded OEM services cover precision-machined hardwood and hardwood-veneered plywood components, small to mid-sized furniture-grade assemblies, drawer systems, and fully finished box builds. Gerstner also offers felt-lining, custom compartmentalization, hardware installation, final packaging, and optional white-label branding. All services are handled at its Dayton, Ohio, facility.

Rather than competing in high-volume, low-cost segments, the company prioritizes repeatable, reliable production with an emphasis on quality. As more businesses seek to stabilize their supply chains through domestic partnerships, Gerstner is positioning itself as a consistent and trusted option for small to midsize manufacturing needs.

“More companies are coming back to U.S.-based manufacturing because they need assurance of delivery, quality, and service,” Brown said. “We’re ready to support that shift with scalable production runs that meet high standards.”

Founded in 1906, Gerstner & Sons remains among the few American woodworking manufacturers operating at its level of craftsmanship. The company’s expansion of OEM capabilities aims to serve a range of industries—including retail, hardware, lifestyle, and design—helping brands bring products to market without sacrificing quality.

About H. Gerstner & Sons

H. Gerstner & Sons is a Dayton, Ohio-based woodworking manufacturer known for its precision-crafted tool chests and fine wood products. Established in 1906, the company continues to serve professionals, collectors, and business clients with consistent quality and attention to detail.

With a strong Made in USA focus, Gerstner & Sons also supports OEM clients with scalable, high-integrity woodworking solutions, from drawer systems to complete finished assemblies.

Media Contact
Company Name: Gerstner & Sons
Contact Person: Kim Brown
Email: Send Email
Phone: 513-509-6051
Country: United States
Website: https://www.gerstnerusa.com

Streetwear Clothing Brand Defi Design Launches DEFI’s Spring/Summer 2025 Capsule Collection

Fashion leader defies expectations in fashion, identity, and attitude, as a fashion label and a cultural force

NEW YORK – May 9, 2025 – Defi Design, the streetwear company known for its Defi streetwear clothing, today announced the launch of its Spring/Summer 2025 Capsule Collection. The fashion brand is introducing new signature pieces, including the adjustable gender-neutral Skirt X, as well as Defi’s debut of gender-fluid streetwear silhouettes.

Defi streetwear celebrates bold, expressive, and unapologetic individuality with the drop of its new fashion line. The Defi Capsule Collection reflects an innovative creative direction and leans into designs with high-quality materials, especially premium denim. The new Skirt X, for example, is fabricated with high-quality denim and is fully adjustable, with an edgy raw-edge finish.

The company’s introduction of its new line represents a brand evolution designed with the latest streetwear trends. The garments offer sharper cuts, premium fabrics, and an even bolder voice in streetwear.

“Defi supports the next generation in defying expectations in fashion, identity, and attitude,” said a spokesperson for Defi Design. “Every piece we create blends confident design with premium construction, designed for people who ‘wear their mindset on their sleeve.’”

Premium, high-quality denim pieces like the innovative, adjustable Skirt X gender-fluid silhouettes that push beyond traditional menswear/womenswear boundaries will meet the need for people whose individual fashion rules are theirs alone.

“Our boundary-pushing designs, and a cultural message rooted in defiance, self-expression, and street authenticity, gives Defi a distinct look and attitude,” added the spokesperson. “We are providing fresh, updated online visuals for clients, that sync with the refreshed brand identity.”

Defi has added comprehensive international fulfillment capabilities to serve its growing customer base across the U.S. and Europe.

For more information and for updates on the new drop visit, https://defidesign.shop/

Media Contact
Company Name: Defi
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://defidesign.shop/

Trelos Finance Strengthens Position as Key Mortgage Broker for Tradies Following Strong 2024 Growth

Sydney, NSW – May 9, 2025 – Trelos Finance, a specialist mortgage brokerage based in Sydney, continues to solidify its position as a trusted partner for Australian tradies following a year of significant growth in 2024. It has reported a 40% year-on-year increase in tradie-led inquiries in the past year, with one in four clients identifying as a self-employed business owner or tradesperson. The firm’s expertise in navigating irregular income structures and simplifying the lending process for tradies has been central to this growth.

Trelos Finance Founder Nick Lissikatos

As access to traditional lending becomes increasingly challenging for workers with irregular income, Trelos Finance has developed a proven methodology for securing home loan approvals with as little as a 5% deposit. The firm specialises in presenting complex financial profiles, including ABN-based income, BAS statements, and multiple income streams, in a way that aligns with lender requirements, helping tradies access competitive home loan products despite fluctuating earnings.

Founder and lead broker, Nick Lissikatos, who brings over a decade of industry experience, emphasised the importance of understanding self-employed clients’ financials beyond surface-level documentation.

“Self-employed Australians, particularly those working in trades, are too often overlooked by mainstream lenders,” said Nick. “We cut through the nonsense and focus on real outcomes, offering lending solutions that reflect the realities of self-employed income.”

Throughout 2024, Trelos Finance assisted clients across a range of trades, including plumbing, electrical, carpentry, bricklaying, and tiling, in purchasing their first homes, upgrading family residences, and refinancing existing loans. On average, tradie clients who worked with Trelos Finance saved between $250 to $500 per month by switching to more suitable lending products. This has positioned the firm strongly for 2025, as more self-employed Australians explore refinancing options in response to shifting interest rate environments.

Building on its milestones, Trelos Finance plans to deepen its engagement with Australia’s growing base of self-employed workers. The company is committed to nurturing long-term client relationships and delivering straightforward solutions and practical outcomes for Australians seeking greater financial independence.

“As the self-employed sector grows, our commitment remains the same: simplifying the lending process and helping more Australians achieve their property goals,” added Nick.

For more information about Trelos Finance and to schedule an appointment, please visit https://trelosfinance.com.au/.

Socials: Instagram, YouTube, LinkedIn, TikTok

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Trelos Finance
Contact Person: Nick Lissikatos
Email: Send Email
Phone: (0402) 991-164
Country: Australia
Website: https://trelosfinance.com.au/

Window Tinting Tucson Experts Ranked By Customers As #1

Window Tinting Tucson Experts Ranked By Customers As #1
Car Kulture Detail brings over five years of certified expertise in auto detailing, paint correction, ceramic coating, and paint protection film (PPF) to Tucson, AZ. The company is committed to using premium-quality products and the latest techniques to ensure that the customer’s vehicle receives the highest level of care.

Car Kulture and Cristian Rojas are pleased to announce that their five years in operation have ranked them as Tucson’s trusted vehicle protection and enhancement leader. In addition to window tinting Tucson professionals offer paint protection film (PPF), custom vehicle wraps, ceramic coatings, paint correction, and auto detailing. Whether the customer wants to preserve the car’s value, enhance its appearance, or protect it from the elements, Car Kulture’s tailored solutions meet their needs. Car Kulture Details keeps the vehicle in pristine condition and ensures it stands out on the road.

A spokesperson for Car Kulture says, “Beat the Arizona heat and enhance your ride with Car Kulture’s premium window tinting. We offer 99% UV protection, glare reduction, and increased privacy with a lifetime warranty. Our products provide maximum heat rejection and increased privacy and security. We offer a wide selection of premium films and various packages to fit your preferences and needs. You can enhance your vehicle’s comfort and appearance with our professional window tinting services. Our expert technicians use premium films to provide superior UV protection, heat reduction, and a sleek, customized finish. We use only the highest quality window films from leading brands, ensuring durability and performance in Tucson’s harsh climate.”

Additional details are available at https://www.carkulturetucsonaz.com/.

The window tint packages are available in various options, depending on the customer’s preferences. These include the Front Two Windows package, a Whole Car Tinting package, a Windshield Add-On package, and a Visor Add-On package. Each package provides 99% UV protection and 99% heat rejection. The Whole Car Tinting package offers comprehensive UV and heat protection across all windows, enhancing privacy and style. It is perfect for maximizing comfort and safeguarding interiors year-round. None of the tinting packages have signal interference–none. Tint packages provide increased privacy and comfort. Customers can choose an enhanced tint style for an even more appealing appearance. Bookings for vehicle enhancement can be easily made by phone or online.

The expert installers are trained, so each customer is happy with the final result. They use only the highest quality window films from leading brands, ensuring durability and performance in Tucson’s harsh climate. The Personalized service means that the technicians help customers choose the perfect type and shade to meet their needs and style preferences.

Car Kulture window tints are backed by a lifetime warranty. The benefits of Tucson window tinting include protection from the city’s intense heat and sun. Window tinting protects from harmful UV rays that can damage skin and fade the car’s interior. The tinting reduces interior temperatures to keep the vehicle cooler and more comfortable. Tinting minimizes sun glare, improves visibility and reduces eye strain; it increases privacy by making it more difficult to see inside the vehicle. Tinting gives the vehicle a sleek and stylish look.

Arizona’s law has specific regulations on window tint darkness. Non-reflective tint is allowed on the top five inches of the windshield. Front side windows must allow more than 33% of light in. Any darkness can be used on the back side windows. Any darkness on the rear window can be used if the vehicle has two outside mirrors. The pros at Car Kulture ensure that the customer’s tint complies with all Arizona laws.

About the Company:

Car Kulture offers its peace-of-mind guarantee to customers desiring quality results. The company uses premium products and methods to ensure satisfaction. For improved comfort, durability and privacy, the company is one of the top firms in the Tucson area.

Media Contact
Company Name: Car Kulture
Contact Person: Cristian Rojas
Phone: +1(520) 535-8017
Address:3837 N Oracle Rd
City: Tucson
State: AZ 85705
Country: United States
Website: https://www.carkulturetucsonaz.com/

Jupillo.co.uk Expands Services with Free Bathroom Renovation Quotes for Scottish Homeowners

Jupillo.co.uk Expands Services with Free Bathroom Renovation Quotes for Scottish Homeowners

Leading home improvement platform Jupillo.co.uk is proud to announce the launch of its new Bathroom Quotes service, designed to help Scottish homeowners transform their bathrooms without the stress, hidden costs, or unreliable contractors.

Available now at jupillo.co.uk/bathroom-quotes, this free service allows homeowners across Scotland to request and compare up to 3 tailored quotes from trusted local bathroom installers. Whether you’re planning a full bathroom renovation, a modern walk-in shower upgrade, or simply want to refresh your space with new fixtures and finishes, Jupillo makes it easy to find the right professionals at the right price.

“Bathrooms are one of the most important and expensive rooms to renovate, so getting it right from the start is essential,” said Ruairidh Lumsden, founder of Jupillo. “We created this service to protect homeowners from overpaying or hiring the wrong company. With Jupillo, you get genuine quotes from vetted specialists who’ve already been quality-checked.”

Key Benefits of the bathroom quotes in Scotland Service:

• Free Quote Matching: No fees or obligations—just three competitive quotes delivered quickly.

• Trusted Installers Only: All contractors are pre-vetted for quality, experience, and reliability.

• Personalised Support: From quote comparison to contractor selection, Jupillo is there every step of the way.

• Scotland-Wide Coverage: Glasgow, Edinburgh, Dundee, Aberdeen, and surrounding areas.

With rising costs and growing demand for home improvements, many homeowners are looking for smarter ways to manage their budgets and find professionals they can rely on. Jupillo’s bathroom quote service addresses that need by simplifying the process, removing the guesswork, and delivering peace of mind.

Whether you’re looking for luxury bathroom suites, compact en-suites, or accessible walk-in showers, Jupillo connects you with the right experts to bring your vision to life—on time and on budget.

About Jupillo

Jupillo is a Scotland-based home renovation platform that helps homeowners get quotes from vetted professionals for services like bathrooms, kitchens, roughcasting, and more. Jupillo is committed to providing an easier, safer way to connect with tradespeople by offering personalised support, quality assurance, and transparent pricing.

Media Contact
Company Name: Jupillo
Contact Person: Ruairidh Lumsden
Email: Send Email
Phone: 0800 677 1055
Address:2 the pleasance halbeath, Dunfermline
City: Glasgow
Country: Scotland
Website: www.jupillo.co.uk/bathroom-quotes/

Adrenocortical Carcinoma Market on Track for Major Expansion by 2034, According to DelveInsight | Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals

The Key Adrenocortical Carcinoma Companies in the market include – Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals, and others.

 

DelveInsight’s “Adrenocortical Carcinoma Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Adrenocortical Carcinoma, historical and forecasted epidemiology as well as the Adrenocortical Carcinoma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Adrenocortical Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenocortical Carcinoma Market Forecast

 

Some of the key facts of the Adrenocortical Carcinoma Market Report:

  • The Adrenocortical Carcinoma market size was valued ~USD 23 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In April 2025, Cytovation ASA, a clinical-stage oncology firm developing the first-in-class bifunctional peptide CY-101, has secured NOK 62 million (approximately USD 6 million) in funding, primarily from existing investors, with Sandwater leading the round. The proceeds will support the progression of CY-101 into a multinational Phase 2 clinical trial for patients with adrenocortical carcinoma, scheduled to commence in late 2025, with initial clinical data anticipated in 2026.

  • In January 2025, Cancer Research UK, Cytovation, and the Norwegian Cancer Society entered into a collaboration to advance Cytovation’s lead candidate, CY-101, into a multinational Phase 2 clinical trial targeting adrenocortical carcinoma (ACC). CY-101 is a synthetic peptide with dual-action capabilities: it selectively eliminates cancer cells while initiating a systemic immune response and concurrently blocks the Wnt/β-catenin signaling pathway—a major contributor to immunotherapy resistance in cancers like ACC.

  • In 2023, the United States had the largest number of new Adrenocortical Carcinoma cases among Western nations, making up nearly 27% of the total cases in the 7MM. The combined total for the EU4 and the UK represented about 53% of the cases in the 7MM, while Japan accounted for just 20% of the overall cases.

  • According to DelveInsight’s assessment in 2023, there were 1,245 new cases of Adrenocortical Carcinoma (ACC) in the 7MM. These cases are expected to see an upward trend with a projected CAGR during the forecast period from 2024 to 2034.

  • In 2023, 40% of males and 60% of females in the 7MM had Adrenocortical Carcinoma (ACC). This indicates a lower incidence of ACC in males compared to females.

  • In 2023, EU4 and the UK reported 658 incident cases of Adrenocortical Carcinoma. These numbers are anticipated to rise in the coming years due to improved diagnostic capabilities and heightened disease awareness.

  • In 2023, Japan recorded 247 incident cases of Adrenocortical Carcinoma. DelveInsight projects that by 2034, the total number of cases in Japan is expected to decline due to the decreasing population and other factors.

  • According to DelveInsight’s analysis, incident cases of Adrenocortical Carcinoma were categorized into four age groups: 60 years. In the 7MM in 2023, the highest number of cases occurred in the 41–60 years age group, followed by those aged >60 years, 20–40 years, and

  • Key Adrenocortical Carcinoma Companies: Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals, and others

  • Key Adrenocortical Carcinoma Therapies: EO2401 + Nivolumab, Dostarlimab, [111In]-FPI-1547 Injection, and others

  • The Adrenocortical Carcinoma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Adrenocortical Carcinoma pipeline products will significantly revolutionize the Adrenocortical Carcinoma market dynamics.

 

Adrenocortical Carcinoma Overview

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that originates in the cortex (outer layer) of the adrenal glands. These glands, located on top of each kidney, produce hormones such as cortisol, aldosterone, and androgens, which are vital for various bodily functions.

 

Get a Free sample for the Adrenocortical Carcinoma Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/adrenocortical-carcinoma-market

 

Adrenocortical Carcinoma Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Adrenocortical Carcinoma Epidemiology Segmentation:

The Adrenocortical Carcinoma market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Adrenocortical Carcinoma

  • Prevalent Cases of Adrenocortical Carcinoma by severity

  • Gender-specific Prevalence of Adrenocortical Carcinoma

  • Diagnosed Cases of Episodic and Chronic Adrenocortical Carcinoma

 

Download the report to understand which factors are driving Adrenocortical Carcinoma epidemiology trends @ Adrenocortical Carcinoma Epidemiology Forecast

 

Adrenocortical Carcinoma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adrenocortical Carcinoma market or expected to get launched during the study period. The analysis covers Adrenocortical Carcinoma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Adrenocortical Carcinoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Adrenocortical Carcinoma Therapies and Key Companies

  • EO2401 + Nivolumab : Enterome/Bristol-Myers Squibb

  • Dostarlimab: UNICANCER

  • [111In]-FPI-1547 Injection: Fusion Pharmaceuticals

 

Discover more about therapies set to grab major Adrenocortical Carcinoma market share @ Adrenocortical Carcinoma Treatment Landscape

 

Adrenocortical Carcinoma Market Strengths

  • The availability of surgical interventions like adrenalectomy offers a viable option for removing the affected adrenal gland, enhancing treatment accessibility.

  • The exclusive approval of Mitotane, listed as an ‘Off-Patent, Off-Exclusivity Drug without an Approved Generic’ in the Orange Book, consolidates its position as the primary therapeutic option for ACC.

 

Adrenocortical Carcinoma Market Opportunities

  • The opportunity lies in the potential of the EO2401 + Nivolumab combination to address immunotherapy resistance, a prevailing challenge in ACC treatment.

  • The therapeutic market of ACC is very scarce, creating an opportunity for key market players to enter the ACC market.

 

Scope of the Adrenocortical Carcinoma Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Adrenocortical Carcinoma Companies: Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals, and others

  • Key Adrenocortical Carcinoma Therapies: EO2401 + Nivolumab, Dostarlimab, [111In]-FPI-1547 Injection, and others

  • Adrenocortical Carcinoma Therapeutic Assessment: Adrenocortical Carcinoma current marketed and Adrenocortical Carcinoma emerging therapies

  • Adrenocortical Carcinoma Market Dynamics: Adrenocortical Carcinoma market drivers and Adrenocortical Carcinoma market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Adrenocortical Carcinoma Unmet Needs, KOL’s views, Analyst’s views, Adrenocortical Carcinoma Market Access and Reimbursement

 

To know more about Adrenocortical Carcinoma companies working in the treatment market, visit @ Adrenocortical Carcinoma Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Adrenocortical Carcinoma Market Report Introduction

2. Executive Summary for Adrenocortical Carcinoma

3. SWOT analysis of Adrenocortical Carcinoma

4. Adrenocortical Carcinoma Patient Share (%) Overview at a Glance

5. Adrenocortical Carcinoma Market Overview at a Glance

6. Adrenocortical Carcinoma Disease Background and Overview

7. Adrenocortical Carcinoma Epidemiology and Patient Population

8. Country-Specific Patient Population of Adrenocortical Carcinoma

9. Adrenocortical Carcinoma Current Treatment and Medical Practices

10. Adrenocortical Carcinoma Unmet Needs

11. Adrenocortical Carcinoma Emerging Therapies

12. Adrenocortical Carcinoma Market Outlook

13. Country-Wise Adrenocortical Carcinoma Market Analysis (2020–2034)

14. Adrenocortical Carcinoma Market Access and Reimbursement of Therapies

15. Adrenocortical Carcinoma Market Drivers

16. Adrenocortical Carcinoma Market Barriers

17. Adrenocortical Carcinoma Appendix

18. Adrenocortical Carcinoma Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Adrenocortical Carcinoma Market on Track for Major Expansion by 2034, According to DelveInsight | Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals

Trigeminal Neuralgia Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Noema Pharma AG, Biohaven Pharmaceuticals, Biogen, Eli Lilly and Company, Novartis

The Key Trigeminal Neuralgia Companies in the market include – Noema Pharma AG, Biohaven Pharmaceuticals, Biogen, Eli Lilly and Company, Novartis, and others.

 

DelveInsight’s “Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Trigeminal Neuralgia, historical and forecasted epidemiology as well as the Trigeminal Neuralgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Trigeminal Neuralgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Trigeminal Neuralgia Market Forecast

 

Some of the key facts of the Trigeminal Neuralgia Market Report:

  • The Trigeminal Neuralgia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

  • In April 2025, Noema Pharma AG announced a clinical study aimed at assessing the effectiveness and safety of basimglurant (NOE-101) at doses ranging from 1.5 mg to 3.5 mg in adults with trigeminal neuralgia (TN). Basimglurant is a strong inhibitor of metabotropic glutamate receptor 5 (mGluR5), which plays a key role in various functions of the central and peripheral nervous systems. Blocking mGluR5 has demonstrated promising potential for relieving pain linked to conditions like Trigeminal Neuralgia.

  • In March 2025, NeuroOne Medical Technologies accelerated its timeline for submitting a 510(k) application to the U.S. Food and Drug Administration (FDA) for its trigeminal nerve ablation technology, now scheduled for May 2025. This innovation is based on the company’s OneRF platform.

  • In December 2024, Noema Pharma, a clinical-stage biotechnology company focused on treating serious central nervous system (CNS) disorders, announced the completion of a Series B extension funding round. The round included an investment from EQT Life Sciences, raising the total capital secured to CHF 130 million (approximately USD 147 million). The funds will advance Noema Pharma’s ongoing four Phase 2 clinical trials, with key data expected in 2025. These trials include continued development of basimglurant (NOE-101), an mGluR5 negative allosteric modulator being tested for trigeminal neuralgia-related severe pain and tuberous sclerosis complex (TSC)-related seizures; gemlapodect (NOE-105), a PDE10a inhibitor in a Phase 2b study for Tourette syndrome and also being developed for childhood-onset fluency disorder (COFD/stuttering); and NOE-115, a monoamine modulator in Phase 2 for treating vasomotor and other menopausal symptoms.

  • In August 2024, Noema Pharma AG, a clinical-stage biotech company developing innovative therapies for severe neuroscience-related disorders, announced the completion of enrollment for the GALENE Phase 2B trial. This double-blind, placebo-controlled study is assessing the efficacy of NOE-101 in managing seizures associated with tuberous sclerosis complex (TSC). NOE-101, also known as basimglurant, is a potent inhibitor of metabotropic glutamate receptor 5 (mGluR5) and is also being clinically investigated for the treatment of trigeminal neuralgia.

  • The National Organisation for Rare Disorders (NORD) reports that women are slightly more likely than men to experience trigeminal neuralgia. Although the actual incidence is unknown, the United States sees between 10,000 and 15,000 new cases annually

  • According to a study by Lambru et al. (2020), the yearly incidence of TN is projected to be 4-29 per 100 000 person-years, while the lifetime prevalence is estimated to be 0.16%-0.3%. Women are more likely than men to have it. With a mean age of onset of 53–57 years and a range of 24-93 years in adult series, the incidence rises with age

  • Key Trigeminal Neuralgia Companies: Noema Pharma AG, Biohaven Pharmaceuticals, Biogen, Eli Lilly and Company, Novartis, and others

  • Key Trigeminal Neuralgia Therapies: Basimglurant, Rimegepant, CNV1014802, Galcanezumab, COA566, and others

  • The Trigeminal Neuralgia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Trigeminal Neuralgia pipeline products will significantly revolutionize the Trigeminal Neuralgia market dynamics.

 

Trigeminal Neuralgia Overview

The trigeminal nerve, or fifth cranial nerve, is one of the most extensively dispersed nerves in the head and is affected by the chronic pain syndrome known as trigeminal neuralgia (TN), sometimes known as tic douloureux. It falls within the category of neuropathic pain, which can be divided into two categories: primary (idiopathic) and secondary.

 

Get a Free sample for the Trigeminal Neuralgia Market Report:

https://www.delveinsight.com/report-store/trigeminal-neuralgia-market

 

Trigeminal Neuralgia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Trigeminal Neuralgia Epidemiology Segmentation:

The Trigeminal Neuralgia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Trigeminal Neuralgia

  • Prevalent Cases of Trigeminal Neuralgia by severity

  • Gender-specific Prevalence of Trigeminal Neuralgia

  • Diagnosed Cases of Episodic and Chronic Trigeminal Neuralgia

 

Download the report to understand which factors are driving Trigeminal Neuralgia epidemiology trends @ Trigeminal Neuralgia Epidemiology Forecast

 

Trigeminal Neuralgia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Trigeminal Neuralgia market or expected to get launched during the study period. The analysis covers Trigeminal Neuralgia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Trigeminal Neuralgia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Trigeminal Neuralgia Therapies and Key Companies

  • Basimglurant: Noema Pharma AG

  • Rimegepant: Biohaven Pharmaceuticals

  • CNV1014802: Biogen

  • Galcanezumab: Eli Lilly and Company

  • COA566: Novartis

 

Discover more about therapies set to grab major Trigeminal Neuralgia market share @ Trigeminal Neuralgia Treatment Market

 

Scope of the Trigeminal Neuralgia Market Report

  • Study Period: 2019–2032

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Trigeminal Neuralgia Companies: Noema Pharma AG, Biohaven Pharmaceuticals, Biogen, Eli Lilly and Company, Novartis, and others

  • Key Trigeminal Neuralgia Therapies: Basimglurant, Rimegepant, CNV1014802, Galcanezumab, COA566, and others

  • Trigeminal Neuralgia Therapeutic Assessment: Trigeminal Neuralgia current marketed and Trigeminal Neuralgia emerging therapies

  • Trigeminal Neuralgia Market Dynamics: Trigeminal Neuralgia market drivers and Trigeminal Neuralgia market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Trigeminal Neuralgia Unmet Needs, KOL’s views, Analyst’s views, Trigeminal Neuralgia Market Access and Reimbursement

 

To know more about Trigeminal Neuralgia companies working in the treatment market, visit @ Trigeminal Neuralgia Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Trigeminal Neuralgia Market Report Introduction

2. Executive Summary for Trigeminal Neuralgia

3. SWOT analysis of Trigeminal Neuralgia

4. Trigeminal Neuralgia Patient Share (%) Overview at a Glance

5. Trigeminal Neuralgia Market Overview at a Glance

6. Trigeminal Neuralgia Disease Background and Overview

7. Trigeminal Neuralgia Epidemiology and Patient Population

8. Country-Specific Patient Population of Trigeminal Neuralgia

9. Trigeminal Neuralgia Current Treatment and Medical Practices

10. Trigeminal Neuralgia Unmet Needs

11. Trigeminal Neuralgia Emerging Therapies

12. Trigeminal Neuralgia Market Outlook

13. Country-Wise Trigeminal Neuralgia Market Analysis (2019–2032)

14. Trigeminal Neuralgia Market Access and Reimbursement of Therapies

15. Trigeminal Neuralgia Market Drivers

16. Trigeminal Neuralgia Market Barriers

17. Trigeminal Neuralgia Appendix

18. Trigeminal Neuralgia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Trigeminal Neuralgia Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Noema Pharma AG, Biohaven Pharmaceuticals, Biogen, Eli Lilly and Company, Novartis

Jupillo Launches New Platform to Connect Scottish Homeowners with Trusted Renovation Experts

Jupillo Launches New Platform to Connect Scottish Homeowners with Trusted Renovation Experts

Glasgow, Scotland – May 09, 2025 – Scottish homeowners looking for hassle-free home improvements now have a powerful new ally: Jupillo.co.uk. Launched this month, Jupillo is a groundbreaking online platform that connects customers with vetted, high-quality contractors for a range of renovation services—from bathroom makeovers and kitchen upgrades to professional wall coatings.

Founded with a mission to simplify the renovation experience, Jupillo takes the stress out of finding reliable tradespeople by personally matching each homeowner with contractors that fit their project goals, budget, and schedule.

“We know how overwhelming it can be to find trustworthy contractors who deliver real value,” said Ruairidh Lumsden. “That’s why we vet every professional on our platform and offer personalised support throughout the renovation journey.”

Key Features:

• Free Quote Matching: Homeowners receive up to 3 tailored quotes from trusted local experts.

• Vetted Contractors Only: Every tradesperson is screened for quality, reliability, and customer satisfaction.

• Support from Start to Finish: From the initial inquiry to project completion, Jupillo offers guidance and transparency every step of the way.

The platform is now live and accepting project requests across Scotland, including in major cities such as Glasgow, Edinburgh, and Aberdeen. Whether you’re planning a bathroom renovation or a full home upgrade, Jupillo Home Improvement Quotes in Scotland ensures you get matched with professionals you can trust—without the guesswork.

To learn more or request a free quote, visit https://jupillo.co.uk.

Media Contact
Company Name: Jupillo
Contact Person: Ruairidh Lumsden
Email: Send Email
Phone: 0800 677 1055
Address:2 the pleasance halbeath, Dunfermline
City: Glasgow
Country: Scotland
Website: www.jupillo.co.uk

Veteran Notary Public Alan Friedland Launches AlanFriedland.com to Serve South Florida Law Firms and Title Companies

Veteran Notary Public Alan Friedland Launches AlanFriedland.com to Serve South Florida Law Firms and Title Companies

Alan Friedland’s Logo
With over 15 years of mobile notary and apostille experience—and 20 years as a Florida mortgage broker—Alan Friedland has built a reputation for precision, professionalism, and reliability across Broward County and Boca Raton. His new website is designed to streamline scheduling and provide legal and real estate professionals with direct access to a full-service mobile notary team, including first and second witnesses for estate and trust document signings.

Pompano Beach, FL – May 9, 2025 – With more than 15 years of experience providing professional mobile notary and apostille services—and 20 years as a licensed Florida mortgage broker—Alan Friedland is proud to announce the launch of his new website, https://alanfriedland.com/ Designed specifically to meet the needs of busy legal and real estate professionals, the website streamlines scheduling and offers direct access to a full-service Mobile Notary Public in Broward County team in Broward County and surrounding South Florida areas.

Friedland’s reputation for precision, professionalism, and reliability has made him a trusted partner among law firms, estate planning attorneys, trust officers, and title companies throughout Broward County and Boca Raton. With the launch of his online platform, he aims to make expert notary and apostille services even more accessible and convenient for professionals who demand fast, accurate execution of critical documents.

“Legal and real estate professionals don’t have time to chase down notaries or worry about whether their documents are being handled properly,” said Friedland. “That’s why I built https://alanfriedland.com/ — to deliver the professional-grade service they need, right when and where they need it.”

Mobile Notary Public with Witness Teams: Estate and Trust Signings Made Easy

One of Friedland’s most in-demand services is Estate Document Signing with Witnesses—ideal for attorneys handling wills, trusts, and power of attorney documentation. His team includes not only licensed notaries but also first and second witnesses, enabling seamless in-office or on-location signings that meet Florida’s strict legal requirements. This is a key convenience for busy professionals who need every detail managed flawlessly.

“Our team understands the importance of discretion, timing, and proper execution, especially in estate and trust matters,” Friedland added. “We’re not just showing up with a stamp—we’re part of ensuring your client’s documents are 100% compliant.”

Fast Florida Apostille Processing for International Documents

In addition to mobile notary services, Friedland provides Florida Apostille Service in Boca Raton and beyond. With years of experience navigating the state’s apostille process, his team delivers expedited document authentication for international use, complete with full tracking and fast turnaround. Whether clients are submitting birth certificates for dual citizenship or legal agreements for international business, Friedland ensures the documents are handled with precision and speed.

“International document processing doesn’t have to be a headache,” said Friedland. “We simplify the process and keep clients informed every step of the way.”

Serving South Florida with Flexibility and Trust

From his home base in Pompano Beach, Friedland offers mobile notary and apostille services throughout Broward County, Boca Raton, and nearby South Florida areas. Whether at law offices, title companies, client homes, hospitals, or eldercare facilities, he and his team are available to meet clients where they are—delivering top-tier notary work with a personal touch.

The new website allows law firms and title professionals to schedule mobile notary and apostille services directly, request witness teams, and receive fast answers to service availability and documentation questions. Alan Friedland’s commitment to reliable, on-time service has made him a go-to resource in South Florida’s legal and real estate communities.

About Alan Friedland

Alan Friedland is a U.S. veteran, former Florida mortgage broker, and certified Mobile Notary Public with over 15 years of experience serving clients across Broward County, Boca Raton, and South Florida. Specializing in estate document signing with witnesses, apostille processing, and real estate closings, Friedland is known for his meticulous attention to detail, integrity, and friendly service.

Visit www.AlanFriedland.com to learn more or to schedule mobile notary and apostille services today.

Media Contact
Company Name: Mobile Notary & Apostille Alan Friedland
Contact Person: Alan Friedland
Email: Send Email
Phone: 954-869-1442
Address:2787 SE 14 Street, Pompano Beach, Florida, 33062
City: Pompano Beach
State: Florida
Country: United States
Website: www.alanfriedland.com/

Secure Access Service Edge Market Innovations 2030, Technology Growth | Top Key Players Include Cisco Systems (US), HPE (US), Verizon (US), Broadcom (US), Fortinet (US)

“Cisco Systems (US), HPE (US), Verizon (US), Broadcom (US), Fortinet (US), Akamai (US), Oracle (US), Juniper Networks (US), Extreme Networks (US), AT&T (US), Palo Alto (US), Checkpoint Software Technologies (Israel), and Huawei (China).”
Secure Access Service Edge (SASE) Market by Offering (SD-WAN, SSE), SD-WAN offering (Software, Appliances), SSE offering (Zero Trust Network Access, Cloud Access Security Broker, Secure Web Gateway, Firewall as a Service) – Global Forecast to 2030.

The Secure Access Service Edge (SASE) market is projected to grow from USD 15.52 billion in 2025 to USD 44.68 billion by 2030, reflecting a compound annual growth rate (CAGR) of 23.6% during the forecast period. Modern SASE solutions increasingly leverage artificial intelligence (AI) and machine learning (ML) to enhance cybersecurity defenses against evolving threats. These technologies analyze network traffic to detect anomalies, such as unusual login attempts and irregular data transfers. By identifying threats early and reducing false positives, security teams can prioritize critical incidents and operate with greater efficiency. This proactive approach enables organizations to strengthen their security posture through intelligent, automated responses that maximize both protection and operational effectiveness.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220384224

Cyber threats are becoming more advanced, persistent, and distributed across multiple entry points, making traditional standalone security tools ineffective. SASE provides a single cloud-based security approach that combines strong threat protection to block malware and unknown attacks, web traffic filtering to control and inspect outbound activity, and strict access enforcement based on user identity. It continuously verifies who the user is, the state of their device, and the situation in which access is requested. This ensures that access is never automatically trusted while also enabling faster detection of threats, better visibility across the network, and automated responses without disrupting the user experience.

By SD-WAN solution, the software segment is expected to hold a higher market share during the forecast period.

SD-WAN software provides companies the ability to administer and optimize their wide-area networks efficiently and with flexibility. The software centralizes control so administrators can establish policies for prioritized traffic, secure connections, and optimize application performance on various network paths. It dynamically routes traffic over broadband, MPLS, or LTE connections to maximize bandwidth while minimizing the usage of costly MPLS networks. It also features security elements such as encryption and firewall protection, delivering a secure and trustworthy network environment. With SD-WAN software, companies can scale their networks quickly, improve performance, and increase reliability, particularly in hybrid or remote work environments. It also provides real-time analytics and visibility into network performance, enabling companies to troubleshoot issues promptly and optimize traffic patterns. The software can easily integrate with cloud applications, providing smooth and unbroken performance. Due to this, organizations can achieve cost savings as well as enhanced user experiences throughout their whole network infrastructure.

By enterprise, the healthcare & life sciences segment is expected to hold the highest growth rate during the forecast period.

In the healthcare sector & life sciences, SASE is playing an important role in safeguarding digital transformation projects as companies increasingly rely on cloud infrastructure, remote employees, and connected healthcare technology. It safeguards sensitive patient data, facilitates compliance with industry regulations such as HIPAA and GDPR, and ensures that users, whether in hospitals, labs, homes, or on the move, can securely access the resources they need. Healthcare organizations benefit from SASE by having simplified management, pervasive security in distributed networks, and greater agility to roll out new applications and services. It streamlines the capability to enable telehealth, clinical research, and digital collaboration with low risk and enhanced operational effectiveness. As healthcare systems expand geographically and involve third-party collaborations, SASE also secures access to data and lowers vulnerabilities in collaborative processes to protect organizations from adapting cyber threats in spite of ever-evolving nature. Also, by integrating security and connectivity into one cloud native architecture, SASE reduces operational overhead and enables more rapid response to new compliance or patient care needs, which is critical in high-risk, data-intensive healthcare environments.

Asia Pacific region is projected to register the highest CAGR during the forecast period.

The Asia Pacific SASE market is growing at a rapid pace as countries embrace hybrid work patterns, expand cloud adoption, and spend on secure digital infrastructure. Digital transformation objectives drive the momentum in Japan, with the likes of Versa Networks and Cato Networks growing their footprint through new products and alliances. India is experiencing robust growth due to programs such as “Make in India” where Versa Networks, Tata Communications, and others are launching integrated SDWAN and cloud-native services in the primary industries. Hybrid work is thriving in Southeast Asia, particularly in Malaysia, Thailand, Vietnam, and the Philippines, and this has driven unmanaged device growth and cloud applications at more than 80% of organizations to favor single vendor configurations for added security and ease. Meanwhile, Australia and New Zealand prioritize integrated platforms in the public sector to enable remote staff and multi-cloud management. Across the region, surging demand for simplified, scalable, and secure networking drives the next generation of SASE adoption.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=220384224

Unique Features in the Secure Access Service Edge Market

SASE uniquely integrates wide-area networking (WAN) capabilities with comprehensive network security functions—including secure web gateways, cloud access security brokers (CASB), firewall-as-a-service (FWaaS), and zero trust network access (ZTNA)—into a single cloud-native platform. This convergence simplifies infrastructure, reduces latency, and supports consistent policy enforcement across all users and locations.

Unlike traditional perimeter-based security models, SASE operates with a cloud-first approach. Its distributed, scalable architecture enables seamless protection of users and devices regardless of their location, making it especially suitable for hybrid and remote work environments. This architecture ensures consistent performance and availability across global deployments.

SASE frameworks rely on user and device identity rather than IP addresses or location for access control. This identity-centric model supports granular, context-aware access decisions, ensuring users are only granted access to the specific resources they need, thereby enforcing zero trust principles.

Advanced SASE solutions utilize AI and ML to continuously analyze traffic patterns, user behaviors, and network anomalies. This enables real-time threat detection, minimizes false positives, and enhances the speed and accuracy of incident response. Predictive analytics also empower security teams to preemptively address vulnerabilities.

Major Highlights of the Secure Access Service Edge Market

Organizations are increasingly adopting zero trust models, and SASE plays a critical role in enabling this shift. By enforcing strict identity verification and least-privilege access policies, SASE supports a zero trust framework that aligns with modern security requirements.

As businesses transition to cloud-based operations and hybrid work environments, SASE provides a secure, scalable, and flexible framework to support distributed workforces. Its cloud-native design ensures consistent performance and security regardless of user location.

The use of artificial intelligence (AI) and machine learning (ML) in SASE solutions enhances threat detection, behavioral analytics, and automated responses. These intelligent capabilities significantly improve operational efficiency and threat mitigation efforts.

The need for centralized control and end-to-end visibility is a key driver in SASE adoption. Organizations benefit from unified dashboards that integrate networking and security metrics, simplifying policy management and improving incident response.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=220384224

Top Companies in the Secure Access Service Edge Market

The major vendors covered in SASE market include Cisco Systems (US), HPE (US), Verizon (US), Broadcom (US), Fortinet (US), Akamai (US), Oracle (US), Juniper Networks (US), Extreme Networks (US), AT&T (US), Palo Alto (US), Checkpoint Software Technologies (Israel), and Huawei (China). These players have incorporated various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions to strengthen their international footprint and capture a greater share of the SASE market. These organic and inorganic strategies have allowed the market players to expand across geographies by offering SASE infrastructure and services.

Cisco Systems

Cisco Systems is a global technology company specializing in networking, cybersecurity, collaboration, and cloud infrastructure, supporting enterprises, service providers, and the public sector with solutions that drive secure digital transformation. Its SD-WAN solution provides centralized branch connectivity, dynamic traffic routing, and integrated security with cloud compatibility and analytics. In SASE, Cisco provides a cloud-native platform that converges networking and security, with identity-based access, secure web gateways, firewall capabilities, and zero trust enforcement. In January 2024, Cisco and Kyndryl collaborated to co-create scalable security edge services, merging their SD-WAN capabilities to enable enterprises to create a strong roadmap for SASE adoption. The partnership aims to speed up secure cloud migrations while streamlining network management. Collectively, they want to provide end-to-end, flexible services that enable the IT needs of the modern enterprise.

Fortinet

Fortinet is a global cybersecurity company offering integrated, automated solutions designed to protect organizations of all sizes, including enterprises, governments, and service providers. Its portfolio spans firewalls, antivirus, intrusion prevention systems, and secure Wi-Fi, delivering end-to-end protection and visibility across networks. Fortinet’s SASE offering provides secure access to the internet, corporate resources, and SaaS applications through a unified platform powered by AI-driven security. It brings together a secure web gateway, zero trust network access, cloud access security broker, firewall-as-a-service, remote browser isolation, secure SD-WAN, and digital experience monitoring delivered through a single operating system and agent for streamlined management and consistent security across all users and locations. Its SD-WAN solution tightly integrates networking and security, allowing organizations to scale and modernize their infrastructure without compromising protection or performance.

Akamai Technologies

Akamai Technologies, Inc. is an American corporation specializing in content delivery networks (CDN), cybersecurity, DDoS protection, and cloud services. Among its enterprise products, Akamai offers a cloud-based zero-trust solution to give users secure, fast, and identity-aware access to private applications without using common VPNs. This solution grants app-level access based on user identity, context, and device posture, and supports both clientless and client-based access for web and non-web applications. It is designed to work seamlessly across multi-cloud and hybrid environments, integrates with identity providers and security information and event management (SIEM) tools, and enhances performance through Akamai’s global edge network and local points of presence. The architecture is designed for scalability and high availability, making deployment easier while enhancing security posture.

Hewlett Packard Enterprise (HPE)

Hewlett Packard Enterprise (HPE) has solidified its position in the Secure Access Service Edge (SASE) market through its HPE Aruba Networking division, offering a unified, AI-powered platform that integrates networking and security functionalities. Following the acquisition of Axis Security in 2023, HPE enhanced its Security Service Edge (SSE) capabilities—encompassing Zero Trust Network Access (ZTNA), Secure Web Gateway (SWG), Cloud Access Security Broker (CASB), and Digital Experience Monitoring (DEM)—to complement its EdgeConnect SD-WAN solutions. This integration enables organizations to deliver secure, seamless access to applications and data from any location, supporting hybrid work environments and cloud adoption. Recognized as a Leader in the 2024 GigaOm Radar Report for single-vendor SASE, HPE’s approach simplifies management, reduces costs, and enhances user experience by providing a comprehensive, edge-to-cloud security solution.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/secure-access-service-edge-market-220384224.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Secure Access Service Edge Market Innovations 2030, Technology Growth | Top Key Players Include Cisco Systems (US), HPE (US), Verizon (US), Broadcom (US), Fortinet (US)